Bios Equity Partners, LP - 15 May 2026 SCHEDULE 13D/A Report for Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN)

Filing manager: Bios Equity Partners, LP
Reporting owner: BIOS ADVISORS GP, LLC
Security: Lantern Pharma Inc. Common Stock, par value $0.0001 per share
Beneficially owned shares: 571,305 shares
Large-stake signal: Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Ownership
4.5%
Beneficial ownership of this reported class.
Shares
571,305 shares
Shares beneficially owned as disclosed.
Event date
15 May 2026
Date tied to the ownership event or amendment.
Accepted by SEC
15 May 2026
EDGAR acceptance date.
How to read this large-stake filing
Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
Compare this filing with the holder history and issuer page before treating the percentage as a current position.
Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership: 4.5%
Symbol: LTRN
Shares outstanding: 12,752,344 shares
SEC form: SCHEDULE 13D/A
Accepted by SEC: 15 May 2026, 16:20:37 UTC
Event date: 15 May 2026
Prior SEC filing: 16 Apr 2026
Source filing: View source filing

Key filing fact

Bios Equity Partners, LP disclosed 4.5% ownership in Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN) on 15 May 2026.

Key facts

Bios Equity Partners, LP filed SCHEDULE 13D/A for Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN).
Disclosed ownership: 4.5%.
Date of event: 15 May 2026.

This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares owned	Shared voting power	Signature	Title	CIK
BIOS ADVISORS GP, LLC	4.5%	571,305	571,305	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001813844
AARON G.L. FLETCHER	4.5%	571,305	571,305	/s/ John Fucci	John Fucci, as Attorney-in-Fact for Aaron G.L. Fletcher	0001789490
CAVU MANAGEMENT, LP	4.5%	571,305	571,305	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001813270
CAVU ADVISORS, LLC	4.5%	571,305	571,305	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001813310
LESLIE W. KREIS	4.5%	571,305	571,305	/s/ John Fucci	John Fucci, as Attorney-in-Fact for Leslie W. Kreis, Jr.	0001813316
BIOS EQUITY PARTNERS, LP	2.1%	266,621	266,621	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001813314
BIOS EQUITY PARTNERS II, LP	2.4%	304,684	304,684	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001813313
BIOS CAPITAL MANAGEMENT, LP	4.5%	571,305	571,305	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001813845
BIOS FUND II NT, LP	0.22%	28,324	28,324	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001728851
BIOS FUND II QP, LP	1.7%	211,566	211,566	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001716869
BIOS FUND II, LP	0.51%	64,794	64,794	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001714576
BP DIRECTORS, LP	0.2%	26,093	26,093	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001813311
BIOS FUND I QP, LP	0.7%	88,769	88,769	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001700297
Bios Fund I, LP	1.2%	151,759	151,759	/s/ John Fucci	John Fucci/Attorney-in-Fact	0001697316

CIK / CUSIP context first

Broader feeds